Mesa Laboratories Shares Bought by Crawford Investment Counsel

Institutional investor increases stake in medical instruments supplier

Mar. 16, 2026 at 9:18am

Got story updates? Submit your updates here. ›

Crawford Investment Counsel Inc. boosted its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 59.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor now owns approximately 1.49% of Mesa Laboratories, a medical instruments supplier based in Lakewood, Colorado.

Why it matters

The increase in institutional ownership of Mesa Laboratories shares suggests growing investor confidence in the company's performance and future prospects within the medical instruments industry.

The details

Crawford Investment Counsel Inc. purchased an additional 30,723 shares of Mesa Laboratories, bringing its total stake to 82,467 shares. The firm cited Mesa Laboratories' position as a global provider of instrumentation products for critical process monitoring, testing and calibration across healthcare, pharmaceutical, and other industries.

  • Crawford Investment Counsel Inc. increased its stake in the third quarter of 2026.

The players

Crawford Investment Counsel Inc.

An institutional investor that manages over $5 billion in assets and has increased its stake in medical instruments supplier Mesa Laboratories.

Mesa Laboratories, Inc.

A global provider of instrumentation products for critical process monitoring, testing and calibration, headquartered in Lakewood, Colorado.

Got photos? Submit your photos here. ›

The takeaway

The increased institutional ownership of Mesa Laboratories suggests growing confidence in the company's ability to capitalize on trends in the medical instruments industry, though the stock still carries a 'Reduce' rating from some analysts.